The implications and management of septic acute kidney injury

Nature Reviews Nephrology

Volumn 7, Issue 4, 2011, Pages 218-225

  Ricci, Zaccaria ^a   Polito, Andrea ^b   Polito, Angelo ^a   Ronco, Claudio ^c  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CONTRAST MEDIUM; DIURETIC AGENT; FENOLDOPAM; FUROSEMIDE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LOOP DIURETIC AGENT; NORADRENALIN; PLACEBO; POLYMYXIN B; VASOPRESSIN;

ACUTE KIDNEY FAILURE; ANTIBIOTIC THERAPY; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS INFUSION; CONTINUOUS RENAL REPLACEMENT THERAPY; DISEASE ASSOCIATION; DIURETIC THERAPY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FLUID RESUSCITATION; FLUID THERAPY; HEMOPERFUSION; HUMAN; HYPERVOLEMIA; HYPOCHLOREMIA; HYPOKALEMIA; HYPONATREMIA; KIDNEY BLOOD FLOW; LOW DRUG DOSE; METABOLIC ALKALOSIS; MORTALITY; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS; SEPTIC SHOCK; URINE VOLUME;

ACUTE KIDNEY INJURY; HUMANS; PROGNOSIS; SEPSIS;

EID: 79953169925     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2011.15     Document Type: Review

References (69)

1. Ronco, C., Kellum, J. A., Bellomo, R. & House, A. A. Potential interventions in sepsis-related acute kidney injury. Clin. J. Am. Soc. Nephrol. 3, 531-544 (2008).
2. Bernard, B. et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29, 1655-1661 (1999). (Pubitemid 29247035)
3. Sharma, V. K. & Howden, C. W. Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis. Pancreas 22, 28-31 (2001). (Pubitemid 32046211)
4. Tablan, O. C. et al. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm. Rep. 53, 1-36 (2004).
5. Finfer, S. et al. Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 360, 1283-1297 (2009).
6. de Jonge, E. et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362, 1011-1016 (2003). (Pubitemid 37186877)
7. de Smet, A. M. et al. Decontamination of the digestive tract and oropharynx in ICU patients. N. Engl. J. Med. 360, 20-31 (2009).
8. Heyland, D. K. et al. Should immunonutrition become routine in critically ill patients? Asystematic review of the evidence. JAMA 286, 944-953 (2001). (Pubitemid 33010341)
9. Foxwell, A. R., Cripps, A. W. & Dear, K. B. Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis. Cochrane Database of Systematic Reviews Issue 4. Art. No.: CD001958 doi:10.1002/14651858.CD001958.pub2 (2006).
10. Douzinas, E. E. et al. Prevention of infection in multiple trauma patients by high-dose intravenous immunoglobulins. Crit. Care Med. 28, 8-15 (2000). (Pubitemid 30091022)
11. Needham, D. M., Truong, A. D. & Fan, E. Technology to enhance physical rehabilitation of critically ill patients. Crit. Care Med. 37, S436-S441 (2009).
12. Bagshaw, S. M. et al. Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med. 35, 871-881 (2009).
13. Zahar, J. R. et al. Inappropriate prescribing of aminoglycosides: risk factors and impact of an antibiotic control team. J. Antimicrob. Chemother. 58, 651-656 (2006).
14. Mueller, C. et al. Incidence of contrast nephropathy in patients receiving comprehensive intravenous and oral hydration. Swiss Med. Wkly 135, 286-290 (2005). (Pubitemid 40827288)
15. Langenberg, C., Bagshaw, S. M., May, C. N. & Bellomo, R. The histopathology of septic acute kidney injury: a systematic review. Crit. Care 12, R38 (2008).
16. Redfors, B., Bragadottir, G., Sellgren, J., Swärd, K. & Ricksten, S. E. Acute renal failure is NOT an "acute renal success"-a clinical study on the renal oxygen supply/demand relationship in acute kidney injury. Crit. Care Med. 38, 1695-1701 (2010).
17. Wan, L., Bellomo, R., Di Giantomasso, D. & Ronco, C. The pathogenesis of septic acute renal failure. Curr. Opin. Crit. Care 9, 496-502 (2003). (Pubitemid 37518649)
18. Dellinger, R. P. et al. for the Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit. Care Med. 32, 858-873 (2004). (Pubitemid 38344143)
19. Rivers, E. et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 345, 1368-1377 (2001).
20. Payen, D. et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit. Care 12, R74 (2008).
21. Bouchard, J. et al. for the Program to Improve Care in Acute Renal Disease (PICARD) Study Group. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 76, 422-427 (2009).
22. Bellomo, R., Wan, L. & May, C. Vasoactive drugs and acute kidney injury. Crit. Care Med. 36, S179-S186 (2008). (Pubitemid 351483049)
23. Russell, J. A. et al. for the VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N. Engl. J. Med. 358, 877-887 (2008). (Pubitemid 351397087)
24. Gordon, A. C. et al. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med. 36, 83-91 (2010).
25. Cruz, D. N., Bagshaw, S. M., Ronco, C. & Ricci, Z. Acute kidney injury: classification and staging. Contrib. Nephrol. 164, 24-32 (2010).
26. Ricci, Z., Cruz, D. N. & Ronco, C. Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat. Rev. Nephrol. doi:10.1038/nrneph.2011.14.
27. DeTorrente, A. et al. Effects of furosemide and acetylcholine in norepinephrine-induced acute renal failure. Am. J. Physiol. 235, F131-F136 (1978). (Pubitemid 9159832)
28. Cantarovich, F., Rangoonwala, B., Lorenz, H., Verho, M. & Esnault, V. L. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am. J. Kidney Dis. 44, 402-409 (2004). (Pubitemid 39164616)
29. Uchino, S. et al. for the Beginning and Ending Supportive Therapy for the Kidney (B. E. S. T. Kidney) Investigators. Diuretics and mortality in acute renal failure. Crit. Care Med. 32, 1669-1677 (2004). (Pubitemid 39050516)
30. Lameire, N., Vanholder, R. & Van Biesen, W. Loop diuretics for patients with acute renal failure: helpful or harmful? JAMA 288, 2599-2601 (2002). (Pubitemid 35386896)
31. Bagshaw, S. M., Gibney, R. T., McAlister, F. A. & Bellomo, R. The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury. Trials 11, 50 (2010).
32. Favia, I., Garisto, C., Rossi, E., Picardo, S. & Ricci, Z. Fluid management in pediatric intensive care. Contrib. Nephrol. 164, 217-226 (2010).
33. Morelli, A. et al. Prophylactic fenoldopam for renal protection in sepsis: a randomised, double-blind, placebo-controlled pilot trial. Crit. Care Med. 33, 2451-2456 (2005). (Pubitemid 41682094)
34. Tumlin, J. A. et al. Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am. J. Kidney Dis. 46, 26-34 (2005). (Pubitemid 40848430)
35. Landoni, G. et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J. Cardiothorac. Vasc. Anesth. 22, 27-33 (2008). (Pubitemid 351179395)
36. Bellomo, R. How to feed patients with renal dysfunction. Blood Purif. 20, 296-230 (2002).
37. Btaiche, I. F., Mohammad, R. A., Alaniz, C. & Mueller, B. A. Amino acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy. Pharmacotherapy 28, 600-613 (2008). (Pubitemid 351620029)
38. Liu, K. D. et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin. J. Am. Soc. Nephrol. 1, 915-919 (2006).
39. Bagshaw, S. M., Cruz, D. N., Gibney, R. T. & Ronco, C. A proposed algorithm for initiation of renal replacement therapy in adult critically ill patients. Crit. Care 13, 317 (2009).
40. Uchino, S. What is 'BEST' RRT practice? Contrib. Nephrol. 165, 244-250 (2010).
41. Ostermann, M. & Chang, R. W. Correlation between parameters at initiation of renal replacement therapy and outcome in patients with acute kidney injury. Crit. Care 13, R175 (2009).
42. Vinsonneau, C. et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 368, 379-385 (2006). (Pubitemid 44108121)
43. RENAL Replacement Therapy Study Investigators. Intensity of continuous renal-replacement therapy in critically ill patients. N. Engl. J. Med. 361, 1627-1638 (2009).
44. VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N. Engl. J. Med. 359, 7-20 (2008).
45. Kellum, J. A. & Ronco, C. Dialysis: results of RENAL-what is the optimal CRRT target dose? Nat. Rev. Nephrol. 6, 191-192 (2010).
46. Vesconi, S. et al. for the DOse REsponse Multicentre International collaborative Initiative (DO-RE-MI Study Group). Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit. Care 13, R57 (2009).
47. Ronco, C. Recent evolution of renal replacement therapy in the critically ill patient. Crit. Care 10, 123 (2006).
48. Honore, P. M., Joannes-Boyau, O., Boer, W. & Collin, V. High-volume hemofiltration in sepsis and SIRS: current concepts and future prospects. Blood Purif. 28, 1-11 (2009).
49. Ricci, Z. et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol. Dial. Transplant. 21, 690-696 (2006). (Pubitemid 43372916)
50. Cole, L. et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit. Care Med. 30, 100-106 (2002). (Pubitemid 34112184)
51. Payen, D. et al. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit. Care Med. 37, 803-810 (2009).
52. Van Wert, R., Friedrich, J. O., Scales, D. C., Wald, R., Adhikari, N. K. for the University of Toronto Acute Kidney Injury Research Group. High-dose renal replacement therapy for acute kidney injury: systematic review and meta-analysis. Crit. Care Med. 38, 1360-1369 (2010).
53. Morgera, S. et al. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit. Care Med. 34, 2099-2104 (2006). (Pubitemid 44305611)
54. Morgera, S. et al. Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am. J. Kidney Dis. 43, 444-453 (2004). (Pubitemid 38298203)
55. Naka, T., Haase, M. & Bellomo, R. 'Super high-flux' or 'high cut-off' hemofiltration and hemodialysis. Contrib. Nephrol. 166, 181-189 (2010).
56. Ronco, C., Piccinni, P. & Kellum, J. Rationale of extracorporeal removal of endotoxin in sepsis: theory, timing and technique. Contrib. Nephrol. 167, 25-23 (2010).
57. De Nitti, C. et al. Choosing new adsorbents for endogenous ultrapure infusion fluid: performances, safety and flow distribution. Int. J. Artif. Organs 24, 765-776 (2001). (Pubitemid 34168268)
58. Kellum, J. A., Song, M. & Venkataraman, R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-?B DNA binding, and improves short-term survival in lethal endotoxemia. Crit. Care Med. 32, 801-805 (2004). (Pubitemid 38340080)
59. Hanasawa, K. et al. Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber. Prog. Clin. Biol. Res. 264, 337-341 (1988).
60. Cruz, D. N. et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit. Care 11, R47 (2007).
61. Vincent, J. L. et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 23, 400-405 (2005).
62. Cruz, D. N. et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301, 2445-2452 (2009).
63. Kida, Y. Polymyxin B hemoperfusion and mortality in abdominal septic shock. JAMA 302, 1969; author reply 1969-1970 (2009).
64. Kellum, J. A. & Uchino, S. International differences in the treatment of sepsis: are they justified? JAMA 301, 2496-2497 (2009).
65. Bellomo, R., Tetta, C. & Ronco, C. Coupled plasma filtration adsorption. Intensive Care Med. 29, 1222-1228 (2003). (Pubitemid 37041147)
66. Formica, M. et al. Hemodynamic response to coupled plasmafiltration- adsorption in human septic shock. Intensive Care Med. 29, 703-708 (2003). (Pubitemid 36609560)
67. Cantaluppi, V. et al. Protective effect of resin adsorption on septic plasma-induced tubular injury. Crit. Care 14, R4 (2010).
68. Ronco, C. & Ricci, Z. Renal replacement therapies: physiological review. Intensive Care Med. 34, 2139-2146 (2008).
69. Ricci, Z. & Ronco, C. Year in review 2008: critical care-nephrology. Crit. Care 13, 227 (2009).